Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
3,281
-264
-7% -$29.9K 0.02% 179
2026
Q1
$395K Buy
3,545
+91
+3% +$10.8K 0.02% 185
2025
Q4
$466K Buy
3,454
+448
+15% +$48.9K 0.02% 185
2025
Q3
$255K Buy
+3,006
New +$184K 0.01% 221

Other funds holding ABVX

Bank of Hawaii's ABVX Position: Q2 2026 in Review

Bank of Hawaii reduced its Abivax (ABVX) stake by 7.4% in Q2 2026, selling an estimated $29.9K and leaving 3,281 shares worth $437K. The position accounts for 0.02% of the portfolio, ranked #179.

Bank of Hawaii first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $466K in Q4 2025. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Bank of Hawaii held 3,281 shares of Abivax worth $437K as of Q2 2026.
  • Bank of Hawaii sold 264 Abivax shares in Q2 2026, an estimated $29.9K.
  • Abivax made up 0.02% of Bank of Hawaii's portfolio in Q2 2026, its #179 holding.
  • Bank of Hawaii first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Bank of Hawaii's Abivax position peaked at $466K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Bank of Hawaii's 13F filing for Q2 2026, filed 14 Aug 2026.